Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)
Recruiting now
Conditions studied: Neoplasms
In brief
The INNOVA project aims to create an advanced multidisciplinary diagnostic platform to support the Italian healthcare system and translational research. In this context, WP7, coordinated by the Pascale Institute and the focus of this study protocol, is responsible for developing a national platform for the multi-omic profiling of cancer patients eligible for precision medicine treatments, with the goal of supporting clinical decision-making.
Key facts
- Study ID
- NCT06884878
- Run by
- National Cancer Institute, Naples
- People needed
- 103
- Starts
- 2024-10-08
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2025-03-24
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Consent to participate in the study
- Age >18 years
- Performance status (PS) 0-1
- Availability of biological samples for multi-omic profiling
- Availability of radiological images for radiomic assessments
- Patients with metastatic disease, i.e., stage IV (except for melanoma, where stage II/III patients eligible for adjuvant therapy may also be considered)
- Patients eligible for targeted therapy and/or immunotherapy
- Patients with aggressive neoplasms, including melanoma, non-small cell lung carcinoma (NSCLC), colon carcinoma (BRAF-mutated, MSI), triple-negative breast cancer, ovarian cancer, and cholangiocarcinoma.
You may not qualify if…
- Previous line of immunotherapy or targeted therapy
- Previous radiotherapy at the sites of the most recent diagnostic biopsy
- Most recent diagnostic biopsy performed >24 months before enrollment
- Absence of measurable lesions
- Presence of active or untreated brain metastases or leptomeningeal carcinomatosis
Where it is running
- Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale — Naples, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.